AI주식인사이트AI Stock Insight
C

온코크로스

382150KOSDAQ자연과학 및 공학 연구개발업

48.3 / 100

Reference Date: 2026-06-10

Financial Score13.0 / 40
News Sentiment21.3 / 25
Momentum4.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, Operating Profit is on a declining trend. Plunged 40.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

OncoCross is a company that enhances drug development efficiency through its AI platform 'RAPTOR AI', which matches optimal diseases with therapies based on gene expression and protein data. It is also developing 'RAPTOR AI v2.0' to analyze next-generation modalities like ADC and TPD, and expanding its B2B market through the 'Neo Omics' service.

Number of Employees

40people

Average Salary

75.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 62.704.0Point
PBR
4.24Industry Average 3.242.5Point

Higher than industry avg (caution)

ROE
-52.79Industry Average -32.093.5Point

1.6x industry avg (good)

Debt Ratio
73.51Industry Average 7.310.0Point

10.1x industry avg (risky)

Trend 2023~20253.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲503.0% (2-year basis)

Operating Profit Growth Rate
0.0 / 3

Avg ▼14.5% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -42.6% (declining, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 4,650Won52-week high 13,87052-week low 4,650
1-month return0.0Point

1m -40.91% (strong drop)

Volume trend3.0Point

Volume flat

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral분기보고서 (2026.03)2026-05-14